Alan F. Denenberg

Davis Polk is advising JP Morgan as financial adviser to Sequenom, Inc. in connection with its $371 million acquisition by Laboratory Corporation of America Holdings. The closing of the…

Davis Polk is advising J.P. Morgan Securities LLC as financial adviser to Cree, Inc. in connection with the $850 million sale of its Wolfspeed Power and RF division, which includes the…

Davis Polk advised McKesson Corporation on its creation of a new health care information technology company, which will combine substantially all of Change Healthcare Holdings, Inc.’s…

Davis Polk is advising Qatalyst Partners as financial adviser to LinkedIn Corporation in connection with its $26.2 billion acquisition by Microsoft Corp. The deal is expected to close this…

Davis Polk advised the representatives of the several underwriters, in connection with an SEC-registered offering by Nevro Corp. of $172.5 million aggregate principal amount of its 1.75%…

Davis Polk is advising JP Morgan as lead financial adviser to Symantec Corporation in connection with its $4.65 billion acquisition of Blue Coat, Inc. The closing of the transaction, which…

Davis Polk advised the joint book-running managers on the SEC-registered offering by Lam Research Corporation of $800 million aggregate principal amount of its 2.800% senior notes due 2021,…

Davis Polk advised the sole bookrunning manager in connection with the public offering of 3,500,000 shares of the common stock of Coherus BioSciences, Inc. at a price to the public of …

Davis Polk advised the joint book-running managers in connection with a $2.75 billion SEC-registered debt offering by Intel Corporation, consisting of $500 million of its 1.700% senior…

Davis Polk advised the joint book-running managers in connection with a $115.1 million SEC-registered offering of 5,479,750 ordinary shares of Theravance Biopharma, Inc. The ordinary shares…